NEWARK, Del. , July 13, 2022 /PRNewswire/ -- FEMSelect, the developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, reported positive study results for the EnPlace system on women between the ages of 33-45. The accepted abstract demonstrated overwhelmingly that the EnPlace approach to the management of symptomatic uterine prolapse in young women reached a very high level of patient satisfaction.

Lead author Masha Ben Zvi , MD, University College London Hospitals NHS Foundation Trust, Urogynecology and Pelvic Floor Surgery unit, presented the data at the American Urogynecologic Society (AUGS) and International Urogynecological Association (IUGA) international scientific meeting held in Austin, Texas , June 15-18, 2022 .

At the presentation, Dr. Ben Zvi reported that EnPlace's mean operating time was only 33 minutes and the mean blood loss was only 32 ml. For the sacrospinous ligament fixation (SSLF) hysteropexy procedure, the overall patient satisfaction rate was 92.5 percent out of 100. She noted the patients all had stage 2-3 symptomatic uterine prolapse and were seeking surgical treatment. Ben Zvi stated that all women were discharged on the operative day except one who went home the following day. No short-term complications occurred as the study showed that all patients' uteri were successfully returned to the anatomically correct position (post-procedure POP-Q C-point was -5).

"This focused study on younger women confirms our overall experience with utilizing the EnPlace procedure over the past four years. The procedure is extremely safe, can be performed in an outpatient setting, and preserves the uterus while restoring normal pelvic anatomy. Furthermore, our patients really appreciate the minimal discomfort and relatively quick return to normal daily living activities," confirmed co-author Vincent Lucente , MD, Chief of Urogynecology, St. Luke's University Health Network, Bethlehem, PA.

FEMSelect's patented EnPlace delivery system enables the precise guidance, insertion and deployment of a small, nitinol anchor for pelvic floor ligament fixation. The approach is performed with minimal dissection. EnPlace has FDA 510(k) clearance and the CE Mark in the EU.

"In this era, when broadening women's healthcare choices is of the utmost importance, EnPlace's minimally invasive system provides an option that is quicker with a shorter recovery period than typical vaginal procedures," stated Debbie Garner , Co-CEO of FEMSelect.

LiNA Medical USA is the national distributor for the EnPlace system.

FEMSelect is a women-led company with a mission to make a lasting impact on women's health by delivering innovative technologies that provide consistent results in a patient-centric manner and dramatically improve outcomes for women. For more information about the EnPlace system, please contact info@femselect.com or visit https://femselect.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/augsiuga-abstract-enplace-minimally-invasive-meshless-ligament-fixation-system-achieves-92-5-patient-satisfaction-301585156.html

Investors are trying to make sense of the markets, in face of conflicting signals. Year-to-date, we’re facing deep losses – but more recently, a sharp rally despite this week’s confirmation that we’re in a recession. Government data released on Thursday showed a 0.9% GDP contraction in Q2, which came on the heels of a 1.6% contraction in Q1. That’s two quarters in a row, the definition of a recession. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, reminds us the ‘conventional wis

Slaying the inflation dragon isn't done with baby steps. Expect much higher interest rates as a headwind for equities.

When Elon Musk decided to terminate his $44 billion deal to purchase Twitter the social-media company sued in the Delaware Court of Chancery. Twitter is suing for “specific performance,” a rare remedy that would require Musk to complete the merger. Unfortunately for Twitter, it isn’t Elon Musk Inc. but Elon Musk the individual who offered to buy the company.

Looking to buy the dip? Start here.

Shares of the Illinois-based drugmaker AbbVie (NYSE: ABBV) were down by a hefty 5% as of 2:32 p.m. ET Friday afternoon. As a result, the Dividend Aristocrat's market capitalization has slipped by a staggering $13.2 billion today. Ahead of the opening bell, AbbVie announced its 2022 second-quarter earnings.

The stock market is down so far this year; despite a rally since mid-June, the S&P is still down 15% year-to-date and the NASDAQ is down 23%. Share price drops like these get investors thinking about portfolio defense, and that naturally brings them around to dividend stocks. Companies can pay out dividends annually, quarterly, or monthly. Quarterly payments are the most common, but for truly defensive investors, monthly payments offer some advantages. Chief among those is the rapid and regular

It is now guiding for third-quarter revenue of $15 billion-$16 billion vs. the $18.67 billion consensus. As for full-year 2022, its EPS expectation is now $2.30, down from its prior forecast of $3.60 and the $3.39 consensus. In terms of revenue for the year, Intel now expects $65 billion-$68 billion, down from $76 billion and well below the $74.4 billion consensus.

(Bloomberg) -- With recession fears mounting—and inflation, the war in Ukraine and the lingering pandemic taking a toll—many tech companies are rethinking their staffing needs, with some of them instituting hiring freezes, rescinding offers and making rounds of layoffs.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekShock July Stock Rally Was a Monster the Fed May Regret SeeingAlito Decries 'Hostility to Religion' in First Public Remarks Since Abortion Deci

(Bloomberg) -- Investors should stay wary of US stocks and bonds as inflation remains a threat and recession looms, according to Rebecca Patterson, chief investment strategist at Bridgewater Associates.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekShock July Stock Rally Was a Monster the Fed May Regret SeeingAlito Decries 'Hostility to Religion' in First Public Remarks Since Abortion Decision Monkeypox is Spreading Fast. Now Kids Are Getting It, TooRockst

After dropping for the first 5 ½ months of the year, the S&P 500 has rebounded 8.5% since June 15 and 4.7% since July 26, the day before the Federal Reserve raised interest rates. Investors have turned enthusiastic toward stocks partly because Fed Chairman Jerome Powell said after the rate hike that the central bank will eventually slow its rate hike campaign. Never mind that the Fed said in its statement announcing the rate increase that it "anticipates that ongoing increases in the target range [for the federal funds rate] will be appropriate."

Alibaba Group Holding has been added to a growing list of Chinese companies that face potential delisting from US stock exchanges, days after the e-commerce giant announced plans to seek a primary listing on Hong Kong's bourse with the aim to diversify its investor base. The US Securities and Exchange Commission (SEC) on Friday included Alibaba, owner of the South China Morning Post, to its watch list of US-listed Chinese firms that face removal from American exchanges under a 2020 law, the Hold

When his green credentials were challenged by a young activist on the election trail, Joe Biden had a simple answer.

Yahoo Finance markets reporter Alexandra Semenova details the losses Cathie Wood's ARK ETF is seeing amid Roku's earnings miss, Teledoc investments, and sale of Coinbase shares.

(Bloomberg) -- Jack Ma is taking a weeks-long tour in Europe after largely disappearing from public view for almost two years, adding to signs that China’s government is easing pressure on the entrepreneur as he steps back from a business empire that had made him one of the country’s most powerful people.Most Read from BloombergRockstar Games Cleaned Up Its Frat-Boy Culture — and Grand Theft Auto, TooBiden, Xi Plan In-Person Meet as Taiwan Tensions IntensifyUS Economy Shrinks for a Second Quarte

Each of these five real estate investment trusts (REITs) currently pays a dividend of greater than 5%. For those willing to accept the risks, that’s a better yield than that of the U. S. Government 10-Year Treasury Note. Each REIT trades on the New York Stock Exchange, so plenty of information on these REITs is available from analysts at respected investment firms. Looking for ways to boost your returns? Check out Benzinga's coverage on Alternative Real Estate Investments: Exclusive Offering For

See who joins GOOGL on this screen of Warren Buffett stocks based on the investing strategy of Berkshire Hathaway's CEO.

If you still think you can't find winning stocks in the S&P 500, you're not looking hard enough.

The company's future is in doubt after losing a key patent litigation

Recessions aren't created equal. This one is rather different.

We wrote a story on Intel on June 8 with a headline of " Intel is Putting Its Negative News Behind It," and concluded that, "I learned early in my career to pay attention when a stock or commodity did not go lower on bearish news -- this was a sign that the news was already discounted. This is how I view the price action on INTC today. Traders could wait a couple of days but I do not expect INTC to make a new low close for the move down.